Medium- and long-term recurrence after radioiodine therapy for differentiated thyroid carcinoma with recombinant human thyrotropin: a meta-analysis

IntroductionRadioactive iodine (RAI) is commonly used in the management of differentiated thyroid cancers (DTCs). However, the long-term efficacy and the risk of tumor recurrence associated with it remain unclear. In particular, the comparison between recombinant human thyrotropin (rhTSH) and thyroi...

Повний опис

Бібліографічні деталі

Автори:	Qixian Yao, Lili Song, Jun Xu, Zhongliang Wu
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2024-12-01
Серія:	Frontiers in Endocrinology
Предмети:	recombinant human thyroid stimulating hormone differentiated thyroid carcinoma long-term recurrence thyroid hormone withdrawal radioactive iodine
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1474121/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!